Lee S K, Hughes D C, Stevens L M. "一种的合成方法" [P]. US Patent, US 11574346 B2, 2025-01-13.
Sørensen M, Mueller T C, Nielsen H. "Method for the Synthesis of 162402-33-7
2-[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]piperidine" [P]. European Patent, EP 3624383 A1, 2019-06-27.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2016, 1135, 5967-5990.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2019, 2113, (10), 7956-7976.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 162402-33-7
2-[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]piperidine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 2192, (7), 7605-7631.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2012, 974, (7), 5177-5184.